Programming - Hypertension Scientific Sessions 2020

Basic Science Pathway

8:45 a.m. – 9:10 a.m.
Welcome Remarks
Mitchell S. V. Elkind, MD, MS, FAAN, AHA President, New York, NY
Karen Griffin, MD, FAHA, Hines, IL

9:10 a.m. – 10:00 a.m. Keynote Lecture: Genetics of Primary Aldosteronism
Ute Scholl, MD, Berlin, Germany

10:00 a.m. – 11:00 a.m.
Recent Advances Session 1: Results from SPRINT Sub-studies
Moderator: Suzanne Oparil, MD, FAHA, Birmingham, AL

10:00 a.m. SPRINT HEART FAILURE
Bharathi Upadhya, MD, Winston-Salem, NC

10:20 a.m. What is Good for the Heart is Good for the Brain: SPRINT MIND Results
Mark Supiano, MD, Salt Lake City, UT

10:40 a.m. SPRINT KIDNEY
Tara Chang, MD, MS, Palo Alto, CA

11:00 a.m. – 12:30 p.m.
Recent Advances Session 2: Debate: Should we lower nighttime BP with bedtime dosing of antihypertensive medications?
Moderator: Jordana Cohen, MD, MSCE, Philadelphia, PA

11:00 a.m. Presentation of a Clinical Case (Ground Rounds) and Lecture: Nighttime BP and Chronotherapy in Hypertension and CVD
Marwah Abdalla, MD, MPH, FAHA, New York, NY

DEBATE:
11:30 a.m. Pro: Dose at Bedtime
Ramon C. Hermida, PhD, FAHS, FAHA, Vigo, Spain

11:45 a.m. Con: Dose During the Day
Swapnil Hiremath, MD, MPH, Ottawa, ON
 
12:00 p.m. Response 1
12:05 p.m. Response 2

12:10 p.m. – 12:30 p.m.
Discussion / Q&A

CPCS & Primary Care Pathway

8:45 a.m. – 9:10 a.m.
Welcome Remarks
Mitchell S. V. Elkind, MD, MS, FAAN, AHA President, New York, NY
Karen Griffin, MD, FAHA, Hines, IL

9:10 a.m. – 10:00 a.m. Keynote Lecture: Genetics of Primary Aldosteronism
Ute Scholl, MD, Berlin, Germany

10:00 a.m. – 11:30 a.m.
Clinical Practice/Clinical Science
C01: Angiotensin Degrading Enzymes and Their Therapeutic Potential
Moderator: Daniel Batile, MD, FAHA, Chicago, IL

10:00 a.m. Novel Short ACE2 Variants
Jan A. Wysocki, MD, PhD, Chicago, IL

10:30 a.m. Neprilysin Inhibitors
Mark C. Chappell, PhD, FAHA, Winston-Salem, NC

11:00 a.m. Aminopeptidase A Inhibition
Catherine Llorens-Cortes, PhD, Paris, France

11:30 a.m. - 12:20 p.m.
Clinical Practice/Clinical Science
C02. What Level of Evidence is Needed to Change Clinical Practice? Chlorthalidone vs. HCTZ
Moderator: Tara Chang, MD, MS, Palo Alto, CA

11:30 a.m. Overview of Historical Data and Pharmacologic Differences Between Chlorthalidone and HCTZ
James M. Luther, MD, FAHA, Nashville, TN

11:40 a.m. Randomized Controlled Trial Evidence
William C. Cushman, MD, FAHA, Memphis, TN

12:00 p.m. Big Data Evidence
Paul Muntner, PhD, FAHA, Birmingham, AL

12:20 p.m. - 1:20 p.m.
Clinical Practice/Clinical Science
C03. Emerging Tools and Analytica Approaches in Hypertension in 2020
Moderator: Paul Drawz, MD, Minneapolis, MD 

12:20 p.m. AI/Machine Learning in Blood Pressure Management
Chayakrit Kirttanawong, MD, Houston, TX

12:40 p.m. Cuffless Blood Pressure Measurement
Tammy McLoughlin, MD, PhD, Baltimore, MD

1:00 p.m. Approaches to Out-of-Office Blood Pressure Monitoring in Pediatric Patients
Elaine M. Urbina, MD, MS, FAHA, Cincinnati, OH

Basic Science Pathway

9:00 a.m. – 10:00 a.m.
Recent Advances Session 3: A Focus on Women's Health
Moderator: Styliani Goulopoulou, PhD, FAHA, Fort Worth, TX

9:00 a.m. Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy
Sarosh Rana, MD, MPH, Chicago, IL

9:30 a.m. Estrogen Receptor Signaling in Vascular Remodeling and Stiffness
Sarah H Lindsey, PhD, FAHA, New Orleans, LA

10:00 a.m. – 11:00 a.m.
Recent Advances Session 4: Links Between the Renin-angiotensin System and SARs-CoV-2 and COVID-19
Moderator: Matthew A Sparks, MD, FAHA, Durham, NC

10:00 a.m. ACE2 From Renoprotection to a Potential Therapy for Coronavirus Infection
Daniel Batlle, MD, FAHA, Chicago, IL

10:30 a.m. RAS Inhibitors in Hypertension and Heart Failure: Truths and Mistruths of Treatment in the COVID-19 Era
Jordana Cohen, MD, MSCE, Philadelphia, PA

11:00 a.m. – 12:00 p.m.
Excellence Award Lecture and presentation of the The Marvin Moser Clinical Hypertension Award and the Irvine Page & Alva Bradley Lifetime Achievement Award

11:00 a.m. Introduction of the Excellence Award Lecture

11:05 a.m. Excellence Award Lecture: White Coat Hypertension: Pathophysiological and Clinical Aspects
Giuseppe Mancia, MD, PhD, Milan, Italy

11:35 a.m. The Marvin Moser Clinical Hypertension Award
Jackson T. Wright, MD, PhD, FAHA, Cleveland, OH

11:45 a.m. The Irvine Page & Alva Bradley Lifetime Achievement Award
Anil Bidani, MD, FAHA, Hines, IL

12:00 p.m. – 1:30 p.m.
Clinical Pathways Session sponsored by Hypertension (Zoom session)

Case 1: CONNed in Pregnancy
Dr. Spoorthy Kulkarni, MD, MRCP, Cambridge, UK
Prof. Ian Wilkinson, DM FRCP, Cambridge, UK

Case 2: Renovascular Hypertension: One Size Does Not Fit All - Challenges in Diagnosis and Management
Abhilash Koratala MD FASN, Milwaukee, Wisconsin
Rajesh Mohandas MD FAHA, University of Florida, Gainesville, Florida

CPCS & Primary Care Pathway

9:00 a.m. – 10:15 a.m.
Primary Care - C04. Strategies for Getting Your Practice to Goal
Moderator: Jeffrey Brettler, MD, Los Angeles, CA

9:00 a.m. Initiating and Intensifying Treatment: Do Treatment Algorithms Work?
Romsai Tony Boonyasai, MD, MPH, Baltimore, MD

9:15 a.m. Team-Based Approaches That Work
Eric J. MacLaughlin, PharmD, FASHP, FCCP, BCPS, Amarillo, TX

9:30 a.m. Community-Based Approaches: Barbershops
Keith Ferdinand, MD, FAHA, New Orleans, LA

9:45 a.m. Practice Facilitation to Get to Goal in a Primary Care Network
Shari D. Bolen, MD, MPH, Cleveland, OH

10:15 a.m. – 10:45 p.m.
Primary Care
C05. Hypertension Quality Metrics that Matter

10:15 a.m. Hypertension Quality Metrics that Matter
Valy Fontil, MD, MAS, MPH, San Francisco, CA

11:00 a.m. - 12:00 p.m.
Excellence Award Lecture and presentation of the The Marvin Moser Clinical Hypertension Award and the Irvine Page & Alva Bradley Lifetime Achievement Award

11:00 a.m. Introduction of the Excellence Award Lecture

11:05 a.m. Excellence Award Lecture: White Coat Hypertension: Pathophysiological and Clinical Aspects
Giuseppe Mancia, MD, PhD, Milan, Italy

11:35 a.m. The Marvin Moser Clinical Hypertension Award
Jackson T. Wright, MD, PhD, FAHA, Cleveland, OH

11:45 a.m. The Irvine Page & Alva Bradley Lifetime Achievement Award
Anil Bidani, MD, FAHA, Hines, IL

12:00 p.m. – 1:30 p.m.
Clinical Pathways Session sponsored by Hypertension (Zoom session)

Case 1
CONNed in Pregnancy
Dr. Spoorthy Kulkarni, MD, MRCP, Cambridge, UK
Prof. Ian Wilkinson, DM FRCP, Cambridge, UK

Case 2
Renovascular Hypertension: One Size Does Not Fit All - Challenges in Diagnosis and Management
Abhilash Koratala MD FASN, Milwaukee, Wisconsin
Rajesh Mohandas MD FAHA, University of Florida, Gainesville, Florida

Basic Science Pathway

8:50 a.m. – 11:00 a.m.
Awards Session

8:50 a.m. Introductions

9:00 a.m. Arthur C. Corcoran Memorial Lecture: From Brain to Blood Vessel - Insights from Muscle Sympathetic Nerve Recordings
John Floras, MD, Dphil, FAHA, Toronto, ON

9:20 a.m. Lewis K. Dahl Memorial Lecture: NO News is Good News
Jennifer S. Pollock, PhD, FAHA, FAPS, Birmingham, AL

9:40 a.m. Harriet Dustan Award Lecture: Chemerin - A Connection Between Obesity and Hypertension
Stephanie Watts, PhD, FAHA, East Lansing, MI

10:00 a.m. Donald Seldin Lecture: Regulation of Blood Pressure by Renal Intercalcated Cells
Susan M. Wall, MD, FAHA, Atlanta, GA

10:20 a.m. Mid-Career Award for Research Excellence: Heme Redox Cycling and Blood Pressure Control
Adam Straub, PhD, Pittsburgh, PA

10:40 a.m. Harry Goldblatt Award for Early Career Investigators: Role of Oxidative Protein Modifications in Salt-Induced Hypertension and Kidney Disease
Annet Kirabo, DVM, PhD, FAHA, Nashville, TN

11:00 a.m. – 12:20 p.m.
Recent Advances Session 5: KCVD Council Symposia: BP Genetics 2.0: Beyond Monogenetic Investigation
Moderator: Alicia A McDonough, PhD, FAHA, Los Angeles, CA

11:00 a.m. Genetic Determinants of Blood Pressure Determinants in Trans-Ethnic Association Studies
Adriana Hung, MD, MPH, Nashville, TN

11:20 a.m. Blood Pressure Genetic Risk Score Predicts Blood Pressure Responses to Dietary Sodium and Potassium
Tanika Kelly, PhD, MPH, New Orleans, LA

11:40 a.m. GSTM1 Gene, Diet, and Kidney Disease Progression
Thu H Le, MD, FAHA, Rochester, NY

12:20 p.m. – 1:20 p.m.
Oral Abstracts
AOS1. Preeclampsia, Pregnancy and Pediatric Hypertension
Moderator: Justin L Grobe, PhD, FAHA, Milwaukee, WI

12:20 p.m. Male Sprague Dawley Rats Exposed To Perinatal Hypoxia Are More Susceptible To Angiotensin II-induced Hypertension In Adulthood Vs Females
Lindsay A. Ramirez. Augusta University, Augusta, GA

12:30 p.m. Increased Complement Regulator CD55 Is Associated With A Reduction In Pancreatic Beta Cell Area In Islets Of Rat Offspring Following Chronic Placental Ischemia-induced Hypertension
Jean F Regal, University of Minnesota, Duluth, MN

12:40 p.m. Preeclampsia-induced T Helper-associated Cytokine Imbalances Persist Postpartum
Sabrina M Scroggins, University of Iowa, Iowa City, IA

12:50 p.m. Molecular Profile Of Peripheral Blood Mononuclear Cells In Hypertensive Adolescents With Target Organ Damage
Fnu Mohammed Arif, University of Cincinnati, Cincinnati, OH

1:00 p.m. White Coat Hypertension Stability In Children And Adolescents: Pediatric Nephrology Research Consortium Study
Yosuke Miyashita, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA

1:10 p.m. Comparison Between Ambulatory BP Percentile And Load As Predictors Of Target Organ Damage In Youth
Gilad Hamdani, Schneider Children's Medical Center, Petah Tikva, Israel

CPCS & Primary Care Pathway

8:50 a.m. – 11:00 a.m.
Awards Session

9:00 a.m. Arthur C. Corcoran Memorial Lecture: From Brain to Blood Vessel: Insights from Muscle Sympathetic Nerve Recordings
John Floras, MD, Dphil, FAHA, Toronto, ON

9:20 a.m. Lewis K. Dahl Memorial Lecture: NO News is Good News
Jennifer S. Pollock, PhD, FAHA, FAPS, Birmingham, AL

9:40 a.m. Harriet Dustan Award Lecture: Chemerin: A Connection Between Obesity and Hypertension 
Stephanie Watts, PhD, FAHA, East Lansing, MI

10:00 a.m. Donald Seldin Lecture: Regulation of Blood Pressure by Renal Intercalcated Cells
Susan M. Wall, MD, FAHA, Atlanta, GA

10:20 a.m. Mid-Career Award for Research Excellence: Heme Redox Cycling and Blood Pressure Control
Adam Straub, PhD, Pittsburgh, PA

10:40 a.m. Harry Goldblatt Award for Early Career Investigators: Role of Oxidative Protein Modifications in Salt-Induced Hypertension and Kidney Disease
Annet Kirabo, DVM, PhD, FAHA, Nashville, TN

11:00 a.m. – 12:45 p.m.
Primary Care
C07. Hypertension Management in the Era of Covid-19: Has the Time for Remote Patient Monitoring of Hypertension Finally Arrived?
Moderator: Richard McManus, PhD, Oxford, UK
 
11:00 a.m. Comparing Approaches to Remote Patient Monitoring of Hypertension
Steven A. Yarows, MD, FAHA, Chelsea, MI

11:30 a.m. New Billing Codes for SMBP and ABPM
J Brian B Byrd, MD, FAHA, Ann Arbor, MI

11:50 a.m. Implementation Challenges and Opportunities in Low Income and Minority Patient Populations
Gbenga Ogedegbe, MD, MPH, New York, NY

12:25 p.m. The Importance of Using Validated BP Devices
James Sharman, PhD, Hobart, Australia

12:45 p.m. – 1:30 p.m.
Primary Care
C08. Treating Hypertension in Patients with Co-Morbid Conditions — Case-Based Discussion
Moderator: Valy Fontil, MD, MAS, MPH, San Francisco, CA

12:45 p.m. Heart Failure and or A-fib
Angela L Brown, MD, FAHA, St. Louis, MO

1:00 p.m. Chronic Kidney Disease
Maya Rao, MD, New York, NY

1:15 p.m. COPD
Shannon W. Finks, Pharm.D., FCCP, BCPS, BCCP, AHSCP-CHC, Memphis, TN

Basic Science Pathway

9:00 a.m. – 10:00 a.m.
Early Career Stage Awards Session

9:00 a.m. High Blood Pressure Research Council of Australia Award: Sex differences in para- and peri-renal adipose inflammation in obesity
Maria Jelinic BBSc MSc PhD, Melbourne, Australia

9:15 a.m. New Investigator Awards for Japanese Fellows
Nobuyuki Tokunaga, MD, Kumamoto-shi, Japan

9:30 a.m. AFHRE Award for Patient-Oriented or Clinical Research in Hypertension: Telemedicine And The Barbershop Model Of Hypertension Care For Black Men
Ciantel A. Blyler, PharmD, Cedars-Sinai Medical Center, Los Angeles, CA

9:45 a.m. AFHRE Award for Support of Underrepresented Minorities: Formyl Peptide Receptor-1 Activation Is Crucial For The Cause Of Spontaneous Hypertension In Dahl Salt Sensitive Rats
Jonnelle M. Edwards, PhD, University of Toledo, Toledo, OH

10:00 a.m. – 11:00 a.m.
AOS2. Genetics & Genetic Models of Hypertension
Moderator: Curt Sigmund, PhD, FAHA, Milwaukee, WI

10:00 a.m. Activation Of Neuronal At₁R Exacerbates Hypertension-induced Reduction In Neuronal Function.
Jiaxi Xu, Jiaotong University, Xi'an, China

10:10 a.m. Deletion Of The Alpha Subunit Of EnNaC And MTORC2 Inhibition Attenuate DOCA-salt-induced Endothelial Cell And Vascular Stiffness.
Michael A Hill, University of Missouri, Columbia, MO

10:20 a.m. Histone Deacetylases 1 And 2 Regulate Six2 Function To Maintain Nephron Progenitor Cells During Nephrogenesis
Hongbing Liu, Tulane University, New Orleans, LA

10:30 a.m. Mouse Recombinant Soluble PRR-induced Increase Of Blood Pressure Is Sex-dependant In High Fat-fed Mice
Audrey A Poupeau, University of Kentucky, Lexington, KY

10:40 a.m. Role Of Pro-saas Peptides In Salt Resistance
Ines Armando, George Washington University, Washington, DC

10:50 a.m. The Etiology Of Inverse Salt Sensitivity Of Blood Pressure: Mirna-485-5p Binds To The Dopamine Type 2 Receptor (d2R) Snp Rs6276 And Decreases D2R Expression
John J Gildea, University of Virginia, Charlottesville, VA

11:00 a.m.– 12:00 p.m.
Oral Abstract Sessions 3
AOS3. Neural, Renal & Vascular Mechanisms in Hypertension
Moderator: Alexander Staruschenko, PhD, FAHA, Milwaukee, WI

11:00 a.m. Cholic Acid Supplementation Attenuates Hypertension In Spontaneously Hypertensive Stroke Prone Rats
Bojun Zhang, Baylor College of Medicine, Manvel, TX

11:10 a.m. Glyburide Treatment Improves Aortic Arch Pulse Wave Velocity In A Murine Model Of Alzheimer’S Disease
Nildris Cruz Diaz, Wake Forest School of Medicine, Winston-Salem, NC

11:20 a.m. The Role Of Opioid Receptors In Podocytes In The Development Of Hypertension In Dahl Salt-sensitive Rats
Daria Golosova, Medical College of Wisconsin, Milwaukee, WI

11:30 a.m. Progressive Alterations Of Mitochondrial Bioenergetics In The Kidney During The Development Of Salt-induced Hypertension
Namrata Tomar, Medical College of Wisconsin, Milwaukee, WI

11:40 a.m. Early Life Stress Sensitizes The Angiotensin II-elicited Hypertensive Response
Baojian Xue, University of Iowa, Iowa City, IA

11:50 a.m. Orexin Knockout BPH/2J Hypertensive Mice Still Have Elevated Basal Blood Pressure But Lower Stress Reactivity
Kristy L Jackson, Baker Heart and Diabetes Institute, Melbourne, Australia

CPCS & Primary Care Pathway

9:00 a.m. – 10:00 a.m.
Clinical Practice/Clinical Science
C09. Controversies in Secondary Hypertension: Case-Based Discussions
Moderator: John D Bisoganano, PhD, FAHA, Rochester, NY

9:00 a.m. When Do You Evaluate Patients for Hyperaldosteronism?
J Brian B Byrd, MD, FAHA, Ann Arbor, MI

9:15 a.m. What Factors Should Guide Treatment in Patients with Hyperaldosteronism?
Anand Vaidya, MD, MMSc, Boston, MA

9:30 a.m. When do you Refer Patients for Stenting in Renovascular Hypertension?
Marcel Ruzicka, MD, PhD, FRCPC, Ottawa, ON

9:45 a.m. When do You Evaluate Children for Renovascular Hypertension?
Joseph T. Flynn, MD, MS, FAHA, Seattle, WA

10:00 a.m. – 11:30 a.m.
Clinical Practice/Clinical Science
C10. Difficult Situations in Hypertension Management
Moderator: Debbie L Cohen, MD, Philadelphia, PA

10:00 a.m. Severe Obesity
Michael E. Hall, MD, FAHA, Jackson, MS

10:15 a.m. Refractory Hypertension
Raven Voora, MD, Chapel Hill, NC

10:30 a.m. Baroreflex Failure
Italo Biaggioni, MD, FAHA, Nashville, TN

10:45 a.m. Allostatic Load and Hypertension
Phillip D Levy, MD, MPH, FAHA, Detroit, MI

11:00 a.m. Adolescents
Joshua A Samuels, MD, MPH, FAHA, Houston, TX

This talk will be available OnDemand™
Environmental Contributors to Hypertension
Timothy B Plante, MD, Colchester, VT

11:30 a.m. – 1:10 p.m.
Clinical Practice/Clinical Science
C11. Prescribing and Deprescribing Antihypertensives
Moderator: Angela L Brown, MD, FAHA, St. Louis, MO 
 
11:30 a.m. Intensifying Treatment in the Inpatient Setting
Timothy Anderson, MD, Boston, MA

11:50 a.m. Orthostatic Hypotension
Stephen P Juraschek, MD, PhD, Boston, MA

12:10 p.m. Sick Day Protocols
Laurie Tomlinson, MBBS, MSc, PhD, London, UK

12:30 p.m. Prescribing cascades
Lisa McCarthy, PharmD, MSC, Toronto, ON

12:50 p.m. Discordant Blood Pressures: Masked and White Coat Hypertension
D. Edmund Anstey, MD, MPH, New York, NY